Sepmag Forecasts 400% US Revenue Growth for 2011
2010 sales grew 112% only one year after opening its US offices.
Read MoreMonth: March 2011
Published Data Highlights CDK Inhibitor’s Potential Against Breast Cancer
Targeting CDK2/cyclin E with Cyclacel’s CYC065 reportedly overcomes Herceptin resistance in HER2-positive breast cancer.
Read MoreJoint Commission Previews New Lab Accreditation Standards
Surveys on revised requirements to begin in July.
Read MoreVical, UW Receive Patent For Herpes Simplex Vaccine
The new patent covers DNA vaccines containing the HSV-2 UL49 gene, which encodes the VP22 tegument protein, formulated with or without Vical’s Vaxfectin adjuvant.
Read MoreOxford Instruments Adds More Features To MQC Analyzers
Benchtop analyzer now more compact, powerful, reliable, and easy to use, company says.
Read More